Proceedings of the Nature Research Society, 2017, 1, 01001
Published Online: 15 September 2017 (Commentary)
Cancer has become the chief proving ground-breaking platforms that can be used for precision medicine. Determining the genetic profile of a tumor, detecting key driver mutations, and trying to disable those drivers with targeted therapies so as to “smash” the brakes on malignant and metastatic cells to control proliferation is the modus operandus of Precision Medicine. Now Cancer Nanotechnology aims to do that for old-line drugs and treatment strategies and bring up reality to the Precision Medicine Initiative. However, how far are we from precision and personalization?
João Conde. Time to empower Cancer Nanotechnology Initiative for Precision Medicine, Proceedings of the Nature Research Society, 2017, 1, 010001. doi: 10.11605/j.pnrs.201701001
Received: 02 September 2017, Accepted: 11 September 2017, Published Online: 15 September 2017